Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY2245461 after Multiple Oral Administrations in Healthy Postmenopausal Women.
Phase of Trial: Phase II
Latest Information Update: 03 Nov 2012
At a glance
- Drugs LY 2245461 (Primary)
- Indications Hot flashes; Menopausal syndrome
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 22 Mar 2012 New trial record